Rhumbline Advisers Savara Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Savara Inc stock. As of the latest transaction made, Rhumbline Advisers holds 132,384 shares of SVRA stock, worth $423,628. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132,384

Previous 134,548 1.61%

Holding current value

$423,628

Previous $542,000 3.51%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.96 - $5.07 $8,569 - $10,971	-2,164 Reduced 1.61%	132,384 $561,000
Q2 2024 Aug 01, 2024	BUY	$3.66 - $5.34 $2,265 - $3,305	619 Added 0.46%	134,548 $542,000
Q1 2024 May 09, 2024	BUY	$4.19 - $5.59 $16,194 - $21,605	3,865 Added 2.97%	133,929 $666,000
Q4 2023 Feb 08, 2024	BUY	$3.18 - $4.9 $27,125 - $41,797	8,530 Added 7.02%	130,064 $611,000
Q3 2023 Nov 09, 2023	BUY	$2.97 - $3.88 $63,843 - $83,404	21,496 Added 21.49%	121,534 $459,000
Q2 2023 Aug 08, 2023	BUY	$1.69 - $3.24 $169,064 - $324,123	100,038 New	100,038 $319,000
Q2 2021 Aug 05, 2021	SELL	$1.51 - $2.29 $105,923 - $160,638	-70,148 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$1.17 - $2.33 $819 - $1,631	-700 Reduced 0.99%	70,148 $146,000
Q4 2020 Feb 10, 2021	BUY	$1.0 - $1.47 $10,135 - $14,898	10,135 Added 16.69%	70,848 $81,000
Q3 2020 Nov 12, 2020	SELL	$1.09 - $2.21 $10,736 - $21,768	-9,850 Reduced 13.96%	60,713 $66,000
Q2 2020 Aug 13, 2020	BUY	$1.8 - $3.05 $53,794 - $91,152	29,886 Added 73.47%	70,563 $176,000
Q1 2020 May 06, 2020	BUY	$1.91 - $4.08 $2,102 - $4,492	1,101 Added 2.78%	40,677 $86,000
Q4 2019 Feb 05, 2020	SELL	$0.71 - $4.91 $499 - $3,456	-704 Reduced 1.75%	39,576 $177,000
Q3 2019 Oct 23, 2019	BUY	$2.16 - $3.2 $853 - $1,264	395 Added 0.99%	40,280 $107,000
Q2 2019 Aug 14, 2019	BUY	$2.37 - $11.7 $8,486 - $41,897	3,581 Added 9.86%	39,885 $95,000
Q1 2019 May 01, 2019	SELL	$6.71 - $8.6 $5,274 - $6,759	-786 Reduced 2.12%	36,304 $268,000
Q4 2018 Jan 31, 2019	BUY	$6.27 - $10.92 $82,262 - $143,270	13,120 Added 54.74%	37,090 $281,000
Q3 2018 Nov 07, 2018	BUY	$10.49 - $12.87 $944 - $1,158	90 Added 0.38%	23,970 $268,000
Q2 2018 Aug 06, 2018	BUY	$8.55 - $13.76 $204,174 - $328,588	23,880 New	23,880 $270,000

Others Institutions Holding SVRA

# of Institutions

128

Shares Held

158M

Call Options Held

67.6K

Put Options Held

29.4K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $365M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Savara Inc Transaction History